Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 24, 2015 11:15 ET | Source: Veloxis Pharmaceuticals A/S

Envarsus® XR Demonstrates Differentiated Pharmacokinetic Profile Compared to Twice-Daily Prograf® or Once-Daily Astagraf XL® in Stable Kidney Transplant Patients

Company Announcement no. 16/2015 To: NASDAQ OMX Copenhagen A/S ...
June 24, 2015 11:15 ET | Source: Veloxis Pharmaceuticals A/S

Envarsus® XR udviser differentieret farmakokinetisk profil sammenlignet med to-gange-daglig Prograf® eller én-gang-daglig Astagraf XL® i stabile nyretransplantationspatienter

Selskabsmeddelelse nr. 16/2015 Til: NASDAQ OMX Copenhagen A/S ...
June 12, 2015 12:29 ET | Source: Veloxis Pharmaceuticals A/S

Afgørelse fra amerikansk distriktsdomstol i Veloxis retssag

Selskabsmeddelelse nr. 15/2015 Til: NASDAQ OMX Copenhagen A/S ...
June 12, 2015 12:29 ET | Source: Veloxis Pharmaceuticals A/S

U.S. District Court Rules in Veloxis Litigation

Company Announcement no. 15/2015 To: NASDAQ OMX Copenhagen A/S ...
June 03, 2015 06:45 ET | Source: Veloxis Pharmaceuticals A/S

Warrantprogram - Veloxis Pharmaceuticals A/S udsteder nye aktier i forbindelse med udnyttelse af warrants

Selskabsmeddelelse nr. 14/2015 Til: NASDAQ OMX Copenhagen A/S ...
June 03, 2015 06:45 ET | Source: Veloxis Pharmaceuticals A/S

Warrant Programme - Veloxis Pharmaceuticals A/S issues new shares in connection with exercise of warrants

Company Announcement no. 14/2015 To: NASDAQ OMX Copenhagen A/S ...
May 20, 2015 11:14 ET | Source: Veloxis Pharmaceuticals A/S

Veloxis Pharmaceuticals announces financial results for the first three months of 2015

Company Announcement no. 13/2015 To: NASDAQ OMX Copenhagen A/S Hørsholm, Denmark, 20 May, 2015 Veloxis Pharmaceuticals announces financial results for the first three...
May 12, 2015 07:26 ET | Source: Veloxis Pharmaceuticals A/S

Veloxis Pharmaceuticals A/S er vært for en telekonference i forbindelse med offentliggørelsen af kvartalsrapporten for 1. kvartal 2015 – resultater fra 1. januar til 31. marts 2015

Investor service meddelelse nr. 2/2015 Til: NASDAQ OMX København ...
May 12, 2015 07:26 ET | Source: Veloxis Pharmaceuticals A/S

Veloxis Pharmaceuticals A/S to Host Conference Call Announcing Interim Report for the first Quarter 2015 – results from 1 January to 31 March, 2015

Investor service announcement no. 2/2015 To: NASDAQ OMX Copenhagen ...
May 04, 2015 02:30 ET | Source: Veloxis Pharmaceuticals A/S

Envarsus® XR Demonstrates Improved Pharmacokinetic Profile in African-American Transplant Recipients

Company Announcement no. 12/2015 To: NASDAQ OMX Copenhagen A/S ...